Cargando…
FOXP2 confers oncogenic effects in prostate cancer
Identification oncogenes is fundamental to revealing the molecular basis of cancer. Here, we found that FOXP2 is overexpressed in human prostate cancer cells and prostate tumors, but its expression is absent in normal prostate epithelial cells and low in benign prostatic hyperplasia. FOXP2 is a FOX...
Autores principales: | Zhu, Xiaoquan, Chen, Chao, Wei, Dong, Xu, Yong, Liang, Siying, Jia, Wenlong, Li, Jian, Qu, Yanchun, Zhai, Jianpo, Zhang, Yaoguang, Wu, Pengjie, Hao, Qiang, Zhang, Linlin, Zhang, Wei, Yang, Xinyu, Pan, Lin, Qi, Ruomei, Li, Yao, Wang, Feiliang, Yi, Rui, Yang, Ze, Wang, Jianye, Zhao, Yanyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513481/ https://www.ncbi.nlm.nih.gov/pubmed/37668356 http://dx.doi.org/10.7554/eLife.81258 |
Ejemplares similares
-
The RNA helicase DDX39B activates FOXP3 RNA splicing to control T regulatory cell fate
por: Hirano, Minato, et al.
Publicado: (2023) -
PH domain-mediated autoinhibition and oncogenic activation of Akt
por: Bae, Hwan, et al.
Publicado: (2022) -
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma
por: Brien, Gerard L, et al.
Publicado: (2018) -
Targeting oncogenic KRasG13C with nucleotide-based covalent inhibitors
por: Goebel, Lisa, et al.
Publicado: (2023) -
An acquired scaffolding function of the DNAJ-PKAc fusion contributes to oncogenic signaling in fibrolamellar carcinoma
por: Turnham, Rigney E, et al.
Publicado: (2019)